A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls

Biological Psychiatry

Volumn 40, Issue 12, 1996, Pages 1191-1199

  Knable, Michael B ^a   Hyde, Thomas M ^a   Murray, Angela M ^a   Herman, Mary M ^a   Kleinman, Joel E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

3H SCH 23390; cingulate cortex; D1 receptors; dopamine; prefrontal cortex; schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AUTOPSY; BRAIN CORTEX; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; AUTORADIOGRAPHY; DOPAMINE ANTAGONISTS; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; RECEPTORS, DOPAMINE D1; SCHIZOPHRENIA;

EID: 0030589459     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00116-3     Document Type: Article

References (43)

1. Akbarian S, Bunney WE, Potkin S, et al (1993): Altered distribution of nicotinamide-adenine dinucleotide phosphatediaphorase cells in frontal lobe of schizophrenics implies disturbance of cortical development. Arch Gen Psychiatry 50:169-177.
2. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
3. Andreasen NC, Nasrallah HA, Dunn VD, et al (1986): Structural abnormalities in the frontal system in schizophrenia: A magnetic resonance imaging study. Arch Gen Psychiatry 43:136-144.
4. Andreasen NC, Flashman L, Flaum M, et al (1994): Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 272:1763-1769.
5. Arnsten AFT, Cai JX, Murphy BL, Goldman-Rakic PS (1994): Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116:143-151.
6. Benes FM, Bird ED (1987): An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 44:608-616.
7. Benes FM, Davidson J, Bird ED (1986): Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 43:31-35.
8. Benes FM, Majocha R, Bird ED, Marotta CA (1987): Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry 44:1017-1021.
9. Benes FM, McSparren J, Bird ED, et al (1991): Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996-1001.
10. Benes FM, Vincent SL, Alsterberg G, et al (1992): Increased GABA-A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12:924-929.
11. Berger B, Caspar P, Verney C (1991): Dopaminergic innervation of the cerebral cortex: Unexpected differences between rodents and primates. Trends Neurosci 14:21-27.
12. Berman KF, Weinberger DR (1991): Functional localization in the brain in schizophrenia. In Tasman A, Goldfinger S (eds), American Psychiatric Association Review of Psychiatry, vol 10. Washington, DC: American Psychiatric Press, pp, 24-59.
13. Bogerts B, Hantsch J, Herzer M (1983): A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients and schizophrenics. Biol Psychiatry 18:951-969.
14. Breier A, Buchanan RW, Elkashef A, et al (1992): Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry 49:921-926.
15. Campion D, d'Amato T, Bastard C, et al (1994): Genetic study of dopamine D1, D2 and D4 receptors in schizophrenia. Psychiatry Res 51:215-230.
16. Carlsson A, Lindqvist M (1963): Effects of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140-144.
17. Cichon S, Nothen MN, Rietschel M, et al (1994): Single strand conformation analysis of the dopamine D1 receptor gene reveals no significant mutation in patients with schizophrenia and manic depression. Biol Psychiatry 36:850-853.
18. 3H] SCH23390 binding sites in human prefrontal cortex (Brodmann's area 9). J Neurochem 49:789-796.
19. DeKeyser J, Ebinger G, Vauquelin G (1989): Evidence for a widespread dopaminergic innervation of the human cerebral neocortex. Neurosci Lett 104:281-285.
20. Ferron A, Thierry AM, Le Douarin C, Glowinski J (1984): Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory responses induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res 302:257-265.
21. Goldberg TE, Gold JM, Braff DL (1991): Neuropsychological functioning and time-linked information processing in schizophrenia. In Tasman A, Goldfinger S (eds), American Psychiatric Press Review of Psychiatry, vol 10, American Psychiatric Association Press, Washington, DC: pp 60-78.
22. Goldman-Rakic PS (1991): Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory. In Carrol B (ed), Psychopathology and the Brain. New York: Raven Press, pp. 1-23.
23. Goldman-Rakic PS, Leranth C, Williams SM, et al (1989): Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proceedings of the National Academy of Science 86:9015-9019.
24. Hatta Y, Hatta S, Saito T (1993): Effects of ceruletide on the dopamine receptor-adenylate cyclase system in striatum and frontal cortex of rats treated chronically with haloperidol. Psychopharmacology 110:383-389.
25. Hess EJ, Norman AB, Creese I (1988): Chronic treatment with dopamine receptor antagonist: Behavioral and pharmacologic effects on D1 and D2 dopamine receptors. J Neurosci 8:2361-2370.
26. Jensen S, Plaetke R, Holik J, et al (1993): Linkage analysis of schizophrenia: The D1 receptor gene and several flanking DNA markers. Hum Hered 43:58-62.
27. Knable MB, Hyde TM, Egan MF, et al (1994): Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements. Brain Res 646:217-222.
28. Laruelle M, Jaskiw GE, Lipska BK, et al (1992): D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment. Brain Res 575:47-56.
29. Lidow MS, Goldman-Rakic PS (1994): A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. Proc Nat Acad Sci USA 91:4353-4356.
30. 3H] SCH23390. Neuroscience 40:657-671.
31. Mackenzie RG, Zigmond MJ (1985): Chronic neuroleptic treatment increase D2 but not D1 receptors in rat striatum. Eur J Pharmacol 113:159-165.
32. Matsumoto T, Uchimura H, Hirano M, et al (1983): Differential effects of acute and chronic administration of haloperidol on homovanillic acid levels in discrete dopaminergic areas of rat brain. Eur J Pharmacol 89:27-33.
33. McLean PD (1970): The limbic brain in relation to the psychoses. In Black P (ed), Physiologic Correlates of the Emotions. New York: Academic Press, pp 129-146.
34. Ohara K, Ulpian C, Seeman P, et al (1993): Schizophrenia: Dopamine D1 receptor sequence is normal but has DNA polymorphisms. Neuropsychopharmacology 8:131-135.
35. Sawaguchi T, Goldman-Rakic PS (1991): D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science 251:947-950.
36. Sawaguchi T, Matsumura M (1985): Laminar distribution of neurons sensitive to acetylcholine, noradrenaline and dopamine in the dorsolateral prefrontal cortex of the monkey. Neurosci Res 2:255-273.
37. Scatton B (1977): Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur J Pharmacol 46:363-369.
38. Scatton B, Glowinski J, Julou L (1976): Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administration of neuroleptics. Brain Res 109:184-189.
39. See RE, Aravagiri M, Ellison GD (1989): Chronic neuroleptic treatment in rats produces persisting changes in GABA-A and dopamine D2, but not dopamine D1 receptors. Life Sci 44:229-236.
40. Smiley JF, Goldman-Rakic PS (1993): Heterogenous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: A laminar analysis using the silver-enhanced diaminobenzidine sulfide immunolabeling technique. Cereb Cortex 3:223-238.
41. Stuss DT, Benson DF (1986): The Frontal Lobes. New York: Raven Press.
42. Thierry AM, Mantz J, Milla C, Glowinski J (1988): In Kalivas PW, Nemeroff CB (eds), Proceedings from the Conference on the Meso-Cortical-Limbic Dopamine System. Influence of the Mesocortical/Prefrontal Dopamine Neurons on Their Target Cells. New York: New York Academy of Science, pp. 101-111.
43. Zipursky RB, Lim KO, Sullivan EV, et al (1992): Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 49:195-205.